drugset / Trial / NCT07596095

Induction Agents in ECT: Effects on Seizure Duration, Quality, and Recovery

NCT07596095

RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this observational study is to determine if there are any differences in seizure duration, seizure quality, and recovery time associated with the utilize of different anesthetic induction agents in patients undergoing electroconvulsive therapy. The main question it aims to answer is: Does the choice of anesthetic agent in ECT affect seizure duration, seizure quality, and recovery time? The secondary aim is to measure and compare Patient State Index values on different time of ECT procedure. Participants were informed in detail about the ECT procedure. It was explained that, prior to the induction of anesthesia, a probe would be placed on the face to measure the PSI. Written informed consent was obtained from all participants.

Timeline

Start
2024-07-17
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous
Subject Propofol Small molecule 0.5 mg/kg Intravenous
Subject Propofol Small molecule 1.5 mg/kg Intravenous
Subject Thiopental Small molecule 3 mg/kg Intravenous

Indications

No indication recorded.